TNF and inflammatory bowel disease: Anti-TNF-α therapy appears to be associated with improvements in both endothelial function and arterial stiffness; however, further studies are needed to determine whether the improvements in arterial stiffness and endothelial function are associated with a decreased risk of cardiovascular events in subjects with IBD.